FdaApplication

NDA 214187

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGILEAD SCIENCES INC
application_typeNDA
approval_date2021-06-10

Products (2)

ProductActive ingredientStrengthDosage form
EPCLUSASOFOSBUVIR; VELPATASVIR200MG/PACKET;50MG/PACKETPELLETS;ORAL
EPCLUSASOFOSBUVIR; VELPATASVIR150MG/PACKET;37.5MG/PACKETPELLETS;ORAL

2 products